Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor
CA 2405448 A1 · Owner: Nippon Kayaku Kabushiki Kaisha · Inventors: Seino, Yuko
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A novel method of examining cancer by assaying an autoantibody against MDM2 in the blood and a reagent and a kit therefor. For example cancer is examined by , an immunological method with the use of a peptide fragment of MDM2 as an antigen and anti-MDM2 antibody, which is optionally labeled obtained from , this antigen as an antibody for assaying the autoantibody as described above.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 30, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 30, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 30, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.